Your browser doesn't support javascript.
loading
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Evering, Teresa H; Chew, Kara W; Giganti, Mark J; Moser, Carlee; Pinilla, Mauricio; Wohl, David Alain; Currier, Judith S; Eron, Joseph J; Javan, Arzhang Cyrus; Bender Ignacio, Rachel; Margolis, David; Zhu, Qing; Ma, Ji; Zhong, Lijie; Yan, Li; D'Andrea Nores, Ulises; Hoover, Keila; Mocherla, Bharat; Choudhary, Manish C; Deo, Rinki; Ritz, Justin; Fischer, William A; Fletcher, Courtney V; Li, Jonathan Z; Hughes, Michael D; Smith, Davey; Daar, Eric S.
Afiliação
  • Evering TH; Weill Cornell Medicine, New York, New York (T.H.E.).
  • Chew KW; David Geffen School of Medicine at UCLA, Los Angeles, California (K.W.C., J.S.C.).
  • Giganti MJ; Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.J.G., C.M., M.P., J.R., M.D.H.).
  • Moser C; Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.J.G., C.M., M.P., J.R., M.D.H.).
  • Pinilla M; Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.J.G., C.M., M.P., J.R., M.D.H.).
  • Wohl DA; University of North Carolina, Chapel Hill, North Carolina (D.A.W., J.J.E., W.A.F.).
  • Currier JS; David Geffen School of Medicine at UCLA, Los Angeles, California (K.W.C., J.S.C.).
  • Eron JJ; University of North Carolina, Chapel Hill, North Carolina (D.A.W., J.J.E., W.A.F.).
  • Javan AC; National Institutes of Health, Bethesda, Maryland (A.C.J.).
  • Bender Ignacio R; University of Washington, Seattle, Washington (R.B.).
  • Margolis D; Brii Biosciences, Durham, North Carolina (D.M., Q.Z., J.M., L.Z., L.Y.).
  • Zhu Q; Brii Biosciences, Durham, North Carolina (D.M., Q.Z., J.M., L.Z., L.Y.).
  • Ma J; Brii Biosciences, Durham, North Carolina (D.M., Q.Z., J.M., L.Z., L.Y.).
  • Zhong L; Brii Biosciences, Durham, North Carolina (D.M., Q.Z., J.M., L.Z., L.Y.).
  • Yan L; Brii Biosciences, Durham, North Carolina (D.M., Q.Z., J.M., L.Z., L.Y.).
  • D'Andrea Nores U; Instituto Medico Rio Cuarto, Cordoba, Argentina (U.D.N.).
  • Hoover K; Miami Clinical Research, Miami, Florida (K.H.).
  • Mocherla B; Las Vegas Medical Research, Las Vegas, Nevada (B.M.).
  • Choudhary MC; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts (M.C.C., R.D., J.Z.L.).
  • Deo R; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts (M.C.C., R.D., J.Z.L.).
  • Ritz J; Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.J.G., C.M., M.P., J.R., M.D.H.).
  • Fischer WA; University of North Carolina, Chapel Hill, North Carolina (D.A.W., J.J.E., W.A.F.).
  • Fletcher CV; University of Nebraska Medical Center, Omaha, Nebraska (C.V.F.).
  • Li JZ; Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts (M.C.C., R.D., J.Z.L.).
  • Hughes MD; Harvard T.H. Chan School of Public Health, Boston, Massachusetts (M.J.G., C.M., M.P., J.R., M.D.H.).
  • Smith D; University of California, San Diego, San Diego, California (D.S.).
  • Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California (E.S.D.).
Ann Intern Med ; 176(5): 658-666, 2023 05.
Article em En | MEDLINE | ID: mdl-37068272

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article